PitchSend

Investor Presentaiton

Growth Initiatives Growth Strategies In addition to natural growth from the expansion of the Chinese medical industry, Weigao has plans to further accelerate its growth through a variety of initiatives ranging from product upgrades and diversification to opportunistic acquisitions Opportunistic Acquisitions Replicating the success of Argon by opportunistically source acquisitions to broaden our product suite and further increase our scale Direct Sales Channels • Establishing direct sales channels for select product lines in order to provide Weigao with greater pricing power and in turn, higher margins 06 OPPORTUNISTIC ACQUISITIONS PRODUCT UPGRADES & DIVERSIFICATION Product Upgrades and Diversification 01 05 $ DIRECT SALES CHANNELS WEGO 威高 $ IMPORT SUBSTITUTION 02 Product Partnerships 04 • Partnering with key customers to design bespoke products to better suit client needs and ensure continued demand for our products WEGO威高 X PRODUCT PARTNERSHIPS STRATEGIC COLLABORATION 03 Focus future developments on higher technology and higher margin products where barriers to entry are greater Continuing to diversify our product mix to better combat the evolving market and regulatory environment Import Substitution • Tapping into the high-tech markets in which international players have traditionally dominated at lower costs Importing cutting edge technology to meet the growing demands of Chinese patients Strategic Collaboration Establishing JVs to introduce external capital and expertise to foster further innovation with reduced capital commitments 19 19

View entire presentation